000 | 01956cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030554.0 | ||
008 | 120222s2011 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.18.M.Sc.2011.Kh.E | ||
100 | 0 | _aKhaled Ibrahim Mohammed Elmaghraby | |
245 | 1 | 4 |
_aThe effect of haemodiafiltration on serum level of beta 2 - microglobulin and nerve conduction velocity in chronic haemodialysis patients / _cKhaled Ibrahim Mohammed Elmaghraby ; Supervised Moustafa Mohammed Hassan Taha , Ann Ali Abdelkader , Ashraf Elsherbiny Abdelhady |
246 | 1 | 5 | _aدراسة تأثير الأستصفاء الدموى المفلتر على مستوى بيتا - 2 ميكروجلوبيولين بالدم وسرعة توصيل العصب فى مرضى الأستصفاء الدموى المزمن |
260 |
_aCairo : _bKhaled Ibrahim Mohammed Elmaghraby , _c2011 |
||
300 |
_a129 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
520 | _aHaemodiafiltration ( HDF ) is a dialysis modality that combines the criteria of haemodialysis ( HD ) and haemodiafiltration ( HF ) , so it acts by both diffusion and convection . Beta 2 - microglobulin ( Ý2 MG ) is a marker of the middle molecular weight uremic toxins that it retained in patients with ESRD and its retention results in the manifestions of dialysis related amyloidsis | ||
530 | _aIssued also as CD | ||
653 | 4 | _aBeta 2 | |
653 | 4 | _aHaemodiafiltration | |
653 | 4 | _aMicroglobulin | |
700 | 0 |
_aAnn Ali Abdelkader , _eSupervisor |
|
700 | 0 |
_aAshraf Elsherbiny Abdelhady , _eSupervisor |
|
700 | 0 |
_aMoustafa Mohammed Hassan Taha , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aFatma _eCataloger |
||
905 |
_aNazla _eRevisor |
||
942 |
_2ddc _cTH |
||
999 |
_c37513 _d37513 |